The Long Tail of Peptide Receptor Radionuclide Therapy (PRRT): Uncommon Delayed Renal Dysfunction (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO1248; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Introduction [177Lu]Lu-DOTATATE (Lutathera) is a PRRT approved for metastatic pancreatic neuroendocrine tumors (PNET)...Over the course of his disease, he was treated with temozolomide, sunitinib malate, and surgical resection of the gallbladder, spleen, and pancreatic tail, and was maintained on long-term octreotide; however, significant metastatic tumor burden persisted...Long-term renal surveillance and early nephrology involvement are essential. Further studies are needed to better define this rare complication and guide monitoring strategies."
Cardiovascular • Chronic Kidney Disease • Fibrosis • Gastrointestinal Neuroendocrine Tumor • Hypertension • Immunology • Nephrology • Neuroendocrine Tumor • Renal Disease • Solid Tumor
|
|
Asmad Khan; Izhar Ullah; Noman Salih; Muhammad Owais Hanif; Ali Arif; Kazi S. Khan
|